Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-25-004599
Filing Date
2025-01-17
Accepted
2025-01-17 16:01:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0227890-424b3_neuro.htm 424B3 307629
2 GRAPHIC image_001.jpg GRAPHIC 18567
3 GRAPHIC image_002.jpg GRAPHIC 20961
  Complete submission text file 0001213900-25-004599.txt   363389
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-284051 | Film No.: 25538588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)